Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

Clinical trial NCT05275062 · UNKNOWN

Trial details

NCT number: NCT05275062
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Gastric Cancer Esophagogastric Junction Cancer Pancreatic Cancer

Start date: 2022-02-15
Primary completion: 2024-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.